job News Investors Health professionals Patients Providers Contact TO TO TO IS About Lilly CSR Medicines R&D Lilly Europe Your Health INTEGRITY AND TRANSPARENCY Our experience has taught us that transparency in our work increases the trust of stakeholders (patients, citizens, doctors, administration, suppliers or employees), and we also understand that trust generates credibility. Transparency is necessary to avoid corruption and unethical business practices. At Lilly, we believe that transparency of business practices involving payments or transfers of value to healthcare professionals and institutions is essential for building trust. We understand that these value transfers such as consultancies, lectures, training, teaching, etc. they can be misinterpreted, if they are not made public in a transparent way as they have been until now. As a result, on the one hand, Lilly Spain has joined all the pharmaceutical companies that are members of Farmaindustria, the Spanish employer's association, and has supported the sector's decision to transparently provide information on the relationships of the pharmaceutical industry, both with professionals. as well as with healthcare organizations, considered by us as key partners in the achievement of advances in medicine. Pero además, Lilly está comprometida con los más altos estándares de Integridad en todas las relaciones que establecemos con los diferentes grupos de interés mencionados. Lilly es una compañía global y como tal, debe asegurar una conducta íntegra en todos los mercados en los que está presente. En este sentido, existen dos retos importantes. En primer lugar, que los empleados de la compañía desarrollen prácticas coherentes en todo el mundo. En segundo lugar, esa integridad debe estar adaptada a los marcos legales y culturales de los países en los que se opera. Por ello, la compañía dispone de un potente diseño funcional de su programa de Ethics and Compliance (programa de cumplimiento ético y normativo). Este programa es dirigido por un Chief Ethics and Compliance officer (Director de ética y cumplimiento) en la sede central, responsable de la supervisión del sistema global de Ethics and Compliance que reporta directamente al presidente mundial de la compañía. Además, para preservar la independencia de esta función, cada país dispone de un Director de Ethics and Compliance que reporta directamente a la matriz lo que facilita su labor de monitorización y gestión. OUR COMMITMENT OUR INTEREST GROUPS INTEGRITY AND TRANSPARENCY Our values Compliance program Donations and collaborations PUBLICATION OF VALUE TRANSFERS CSR REPORT AND REPORT ENVIRONMENT LILLY FOUNDATION SOCIAL ACTION UNDERTAKE INHEALTH V EDITION terms and conditions of use data privacy policy copyright cookies policy site map Copyright © 2019 Eli Lilly and Company. All rights reserved Last Updated: 02/20/20 16:54:03